SCHEMBL31259596

SCHEMBL31259596

COc1ccc(CN2C(=O)CCC(=O)c3cccc(F)c32)cc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRM5 P08912 3/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
CASP3 P42574 2/20 0.49
GAA P10253 2/20 0.49
APAF1 O14727 1/20 0.49
SENP8 Q96LD8 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
SENP6 Q9GZR1 1/20 0.49
KDM4E B2RXH2 1/20 0.49
CMA1 P23946 1/20 0.47
GSK3A P49840 2/20 0.45
GSK3B P49841 2/20 0.45
ALDH1A1 P00352 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
BLM P54132 1/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31430163 0.85 MEN1 (0.51) CHRM5MEN1KMT2ACASP3GAA
SCHEMBL15620249 0.81 MEN1 (0.69) CHRM5MEN1KMT2ACASP3GAA
SCHEMBL31399180 0.81 CHRM5 (0.46) CHRM5MEN1KMT2AALDH1A1MAPT
SCHEMBL31399122 0.80 L3MBTL1 (0.58) MEN1KMT2ACASP3GAAAPAF1
SCHEMBL25557092 0.80 L3MBTL1 (0.58) MEN1KMT2ACASP3GAAAPAF1
SCHEMBL31259624 0.79 KDM4E (0.49) CHRM5MEN1KMT2ACASP3GAA
SCHEMBL41389 0.77 CMA1 (0.70) MEN1KMT2ACASP3GAAAPAF1
SCHEMBL31259672 0.77 MEN1 (0.48) CHRM5MEN1KMT2ACASP3GAA
SCHEMBL31259599 0.76 KDM4E (0.60) CHRM5MEN1KMT2ACASP3GAA
SCHEMBL17542838 0.76 CMA1 (0.47) MEN1KMT2ACASP3GAAAPAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4713095-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS Chengdu Anticancer Bioscience, Ltd. (CN) 2026-03-25 EP disclosed
WO-2024240088-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS CHENGDU ANTICANCER BIOSCIENCE , LTD. (CN) 2024-11-28 WO disclosed